Clinical trial
Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome
NCT04283292 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome
- Lead sponsor
- University of Virginia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- March 18, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.